Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Prime Minister Justin Trudeau speaks during a news conference outside Rideau Cottage, in Ottawa, on Dec. 18, 2020.

Adrian Wyld/The Canadian Press

Prime Minister Justin Trudeau says the federal government is spending about $9-million toward research into treatments for COVID-19 as authorities work to deploy hundreds of thousands of vaccines in coming weeks.

Mr. Trudeau says the investment through the National Research Council of Canada will be used to develop treatments to fight COVID-19 and other viral infections.

He says the funding will go to four Canadian companies working on treatment candidates, including two in Montreal and two in Vancouver.

Story continues below advertisement

Mr. Trudeau also announced that Canada is set to receive 125,000 doses of Pfizer-BioNTech a week in January, for a total of 500,000 doses next month.

He says his government has secured agreements for up to 417,000 doses of COVID-19 vaccines to arrive ahead of schedule, including more than 200,000 doses of the Pfizer-BioNTech vaccine next week.

Pending Health Canada approval, he says 168,000 doses of Moderna’s vaccine candidate are scheduled to be shipped by the end of the month.

The Massachusetts-based biotech firm says its COVID-19 vaccine can now be shipped locally without it needing to be frozen at all.

The messenger RNA vaccine from Moderna is on the verge of being authorized for use in Canada and could be approved for use in the United States as early as this past Friday.

Until now, it was believed the vaccine had to remain frozen to at least -20 C until shortly before use, but the company says it can now safely transport liquid doses as refrigerated at between 2 C and 8 C.

A Moderna spokeswoman says this makes the logistics easier of getting the vaccine to remote locations.

Story continues below advertisement

Moderna was already considered less risky to ship than a similar vaccine from Pfizer-BioNTech, which must be kept frozen between -60 C and -80 C, and Canada is planning to send it to the territories, remote Indigenous communities and for use at long-term care homes.

Health Canada’s review team is still waiting for final data on Moderna’s manufacturing process before making its decision but the company plans to start shipping the first doses within 48 hours of getting the green light.

Public-health officials in New Brunswick are preparing to vaccinate front-line health-care workers against COVID-19 on Saturday.

New Brunswick Health Minister Dorothy Shephard says the vaccine clinics are the start of a new path to recovery from the pandemic.

The province, the last in the country to begin its vaccination campaign, plans to inoculate 1,950 workers with their first dose of the Pfizer-BioNTech COVID-19 vaccine, to be followed by a second shot three weeks later.

Editor’s note: (Dec. 18, 2020): A previous version of this story erroneously reported the federal government is spending about $9-billion toward research into treatments for COVID-19. In fact, they’re spending about $9-million.
Prime Minister Justin Trudeau says Canada has signed a contract to receive up to 168,000 doses of Moderna's COVID-19 vaccine before the end of December. The first doses weren't expected until January, but Trudeau says deliveries could now begin within 48 hours of Health Canada giving the the green light. The Canadian Press

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters and editors.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies